Influence of diabetes mellitus on outcome in the era of primary stenting for acute myocardial infarction

Circulation Journal

Volumn 66, Issue 9, 2002, Pages 800-804

  Fujiwara, Kensuke ^a   Hiasa, Yoshikazu ^a   Takahashi, Takefumi ^a   Yamaguchi, Koji ^a   Ogura, Riyo ^a   Ohara, Yoshikazu ^a   Nada, Teru ^a   Ogata, Tatsuro ^a   Yuba, Kenichiro ^a   Kusunoki, Kanji ^a   Hosokawa, Shinobu ^a   Kishi, Koichi ^a   Ohtani, Ryuji ^a  

^a TOKUSHIMA RED CROSS HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Primary coronary stenting

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; CAUSE OF DEATH; EVALUATION; HEART INFARCTION; LENGTH OF STAY; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; STENT; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; SURVIVAL ANALYSIS;

EID: 0036729856     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.800     Document Type: Article

References (34)

1. Acute myocardial infarction in 258 cases of diabetes: Immediate mortality and five-year survival
2. Long-term prognosis after recovery from myocardial infarction: Anine year follow-up of the Perth coronary register
3. Prognosis of patients with diabetes mellitus after acute myocardial infarction
4. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus
5. Myocardial infarct size and mortality in diabetic patients
6. Prevalence and mortality of acute myocardial infarction in patients with diabetes
7. Acute myocardial infarction in diabetic patients
8. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction
9. Diabetic myocardial infarction: Interaction of diabetes with other preinfarction risk factors
10. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis
11. Acute myocardial infarction in diabetes mellitus and significant of congestive heart failure as a prognostic factor
12. Risk factors that discriminate 'high-risk' from 'low-risk' Japanese patients with coronary artery disease
13. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
14. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
15. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction
16. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
17. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy
18. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 Study
19. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience
20. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: Lessons from the GUSTO-I angioplasty substudy
21. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
22. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
23. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The Primary Angioplasty in Myocardial Infarction (PAMI) trial
24. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: A comparison of thrombolytic therapy after primary angioplasty
25. Early mortality after acute myocardial infarction: Observational study in Yamagata, 1993-1995
26. Declining trend in the in-hospital case-fatality rate from acute myocardial infarction in Miyagi Prefecture from 1980 to 1999
27. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI pilot trial
28. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial)
29. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial
30. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
31. Primary stenting in acute myocardial infarction: Influence of diabetes mellitus on angiographic results and clinical outcome
32. Lack of neointimal proliferation after implantation of sirolimuscoated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
33. Sustained suppression of neointimal by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow up
34. The impact of primary stenting in diabetic patients with acute myocardial infarction